Cerus
Cerus Corporation, headquartered in Concord, California, develops and supplies pathogen-protected blood components, aiming to become the leading global blood products company. The company’s INTERCEPT Blood System is approved for platelets, plasma, and Cryoprecipitated Fibrinogen Complex, with ongoing regulatory reviews for red blood cells.
Services
Cerus develops and supplies pathogen-protected blood components to blood centers, hospitals, and patients. The company provides pathogen reduction technologies that enhance blood safety, focusing on protecting blood components from pathogens. Additionally, Cerus offers educational webinars and podcasts on blood safety and pathogen reduction topics, emphasizing their commitment to safeguarding the world's blood supply.
Products
The INTERCEPT Blood System is a cornerstone of Cerus's product offerings. The system includes the INTERCEPT Blood System for platelets and plasma, which is the only pathogen reduction system with both CE Mark and FDA approval. The system for red blood cells is currently under regulatory review in Europe and is in late-stage clinical development in the US. Moreover, the INTERCEPT Blood System of Cryoprecipitation is approved in the US for producing Pathogen Reduced Cryoprecipitated Fibrinogen Complex.
History
Cerus Corporation has nearly three decades of experience in transfusion medicine. The company continuously strives to become the preeminent global blood products company, focusing on innovations in blood safety. Cerus recently consolidated its corporate offices into a new facility in Concord, California, where it also has its headquarters. The company's European headquarters is located in Amersfoort, Netherlands.
Commitment to Diversity, Equity, and Inclusion
Cerus has a strong commitment to diversity, equity, and inclusion within its workforce. Notably, 61% of its global workforce identifies as women, highlighting the company's efforts to promote gender diversity. Cerus also strives to provide a supportive work environment, offering flexible work arrangements, paid parental leave, and comprehensive compensation and benefits packages.
Global Presence
Cerus operates on a global scale, collaborating with leading blood centers and hospitals around the world. The company has dedicated websites for different regions, including the US, Canada, and international markets. Cerus is committed to providing pathogen reduction technologies to blood centers and transfusion services globally, ensuring enhanced blood safety and improved patient outcomes.